Owners Consider Suit Against Breeders’ Cup on Salix
Frank Angst
March 14, 2013
Prominent owners threatened legal action if Breeders’ Cup prohibits race-day Salix at its world championships.
Prominent owners threatened legal action if Breeders’ Cup prohibits race-day Salix at its world championships.
Regulators in eight states have committed to a uniform racehorse medication and drug testing program.
Fatal injuries in North American Thoroughbred races stayed consistent at just under two per 1,000 starts.
Regulators met via conference call March 4 to discuss new model medication rules set to be adopted by RCI.
As in 2012, Salix use is prohibited in Breeders’ Cup races for 2-year-olds but allowed in all other races.
It’s the first in more than a decade, but a recent positive nikethamide test has racing regulators’ attention.
CANTER is celebrating a milestone year for transitioning ex-racehorses into second careers.
The resolution furthers an effort to implement uniform racehorse medication, penalty, and testing rules.
The organization voted to endorse the use of race-day furosemide during this year’s Breeders’ Cup races.
Researchers found that reasons for returning an adopted horse are highly variable and unpredictable.
MRI could detect bone changes indicating a horse is at risk for catastrophic fractures before accidents occur.
A tentative agenda includes consideration of new drug penalty structures and more.
The Maryland Racing Commission voted for a equine medication, penalty, and testing program for racetracks.
Rachel Alexandra’s condition remains serious but has shown some signs of progress
A search committee has been formed to find an equine veterinary medical director for the NYRA.
The board will review and assess fatal equine racing and training injuries at NYRA’s three racetracks.
Stay on top of the most recent Horse Health news with
